Otonomy Drug Miss, BlackBerry Buyback Lead After Hours Movers
Drug stocks Otonomy (OTIC) and PTC Therapeutics (PTCT) led after-hours movers Thursday, as did teen clothing retailer Aeropostale (ARO) and ailing smartphone maker BlackBerry (BBRY). Otonomy, a clinical-stage biopharmaceutical company that specializes in ear drugs, said that its phase two-B OTO-104 drug trial “narrowly missed” its primary endpoint of reducing Meniere’s disease — a chronic condition that the company says is characterized by acute